In vitro effects of aldehydes present in tobacco smoke on gene expression in human lung alveolar epithelial cells

Toxicology in Vitro

Volumn 27, Issue 3, 2013, Pages 1072-1081

  Cheah, Nuan P ^a,b,c   Pennings, Jeroen L A ^b   Vermeulen, Jolanda P ^b   Van Schooten, Frederik J ^a   Opperhuizen, Antoon ^a,b,d  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c HEALTH SCIENCES AUTHORITY   (Singapore)

^d Netherlands Food and Consumer Product Safety Authority (NVWA)   (Netherlands)

Author keywords

Acetaldehyde; Acrolein; Formaldehyde; Gene expression; Tobacco smoke

Indexed keywords

2,5 DIMETHYLFURAN; ACETALDEHYDE; ACROLEIN; ALDEHYDE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FORMALDEHYDE; FURAN DERIVATIVE; HEME OXYGENASE 1; HYDROQUINONE; INTERLEUKIN 8; NICOTINE; PROTEIN FOS; PUMA PROTEIN; TOBACCO SMOKE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG TOXICITY; OXIDATIVE STRESS; TRANSCRIPTION REGULATION; UPREGULATION;

ACROLEIN; ALDEHYDES; CELL LINE, TUMOR; FORMALDEHYDE; FURANS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; HYDROQUINONES; NICOTINE; PNEUMOCYTES; SMOKE; TOBACCO;

EID: 84874708385     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.02.003     Document Type: Article

References (64)

1. Alonso M., Godayol A., Antico E., Sanchez J.M. Assessment of environmental tobacco smoke contamination in public premises: significance of 2,5-dimethylfuran as an effective marker. Environmental Science & Technology 2010, 44:8289-8294.
2. Ashley D.L., Bonin M.A., Hamar B., McGeehin M. Using the blood concentration of 2,5-dimethylfuran as a marker for smoking. International Archives of Occupational and Environmental Health 1996, 68:183-187.
3. Bein K., Leikauf G.D. Acrolein - a pulmonary hazard. Molecular Nutrition & Food Research 2011, 55:1342-1360.
4. Belluzzi J.D., Wang R., Leslie F.M. Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 2005, 30:705-712.
5. Breit S.N., Johnen H., Cook A.D., Tsai V.W., Mohammad M.G., Kuffner T., Zhang H.P., Marquis C.P., Jiang L., Lockwood G., Lee-Ng M., Husaini Y., Wu L., Hamilton J.A., Brown D.A. The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism. Growth Factors 2011, 29:187-195.
6. Burcham P.C., Raso A., Thompson C.A. Toxicity of smoke extracts towards A549 lung cells: role of acrolein and suppression by carbonyl scavengers. Chemico-Biological Interactions 2010, 183:416-424.
7. Cacace S., Plescia F., Barberi I., Cannizzaro C. Acetaldehyde oral self-administration: evidence from the operant-conflict paradigm. Alcoholism, Clinical and Experimental Research 2012, 36(7):1278-1287.
8. Charles S.M., Jia C., Batterman S.A., Godwin C. VOC and particulate emissions from commercial cigarettes: analysis of 2,5-DMF as an ETS tracer. Environmental Science & Technology 2008, 42:1324-1331.
9. Chen Z., Xie F., Ma G., Feng Y., Qian Q., Liu N. Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a Chinese population. Molecular Biology Reports 2011, 38:5085-5091.
10. Cheng J.C., Chang H.M., Leung P.C. Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. Endocrinology 2011, 152:2987-2995.
11. Counts M., Morton M., Laffoon S., Cox R., Lipowicz P. Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions. Regulatory Toxicology and Pharmacology 2005, 41:185-227.
12. Croce M.V., Colussi A.G., Price M.R., Segal-Eiras A. Identification and characterization of different subpopulations in a human lung adenocarcinoma cell line (A549). Pathology Oncology Research: POR 1999, 5:197-204.
13. Davis A.P., King B.L., Mockus S., Murphy C.G., Saraceni-Richards C., Rosenstein M., Wiegers T., Mattingly C.J. The comparative toxicogenomics database: update 2011. Nucleic Acids Research 2011, 39:D1067-1072.
14. Duong A., Steinmaus C., McHale C.M., Vaughan C.P., Zhang L. Reproductive and developmental toxicity of formaldehyde: a systematic review. Mutation Research 2011, 728:118-138.
15. Factor P., Akhmedov A.T., McDonald J.D., Qu A., Wu J., Jiang H., Dasgupta T., Panettieri R.A., Perera F., Miller R.L. Polycyclic aromatic hydrocarbons impair function of beta2-adrenergic receptors in airway epithelial and smooth muscle cells. American Journal of Respiratory Cell and Molecular Biology 2011, 45:1045-1049.
16. Frijters R., Heupers B., van Beek P., Bouwhuis M., van Schaik R., de Vlieg J., Polman J., Alkema W. CoPub: a literature-based keyword enrichment tool for microarray data analysis. Nucleic Acids Research 2008, 36:W406-410.
17. Fujioka K., Shibamoto T. Determination of toxic carbonyl compounds in cigarette smoke. Environmental Toxicology 2006, 21:47-54.
18. Galbiati V., Martinez V., Bianchi S., Mitjans M., Corsini E. Establishment of an in vitro photoallergy test using NCTC2544 cells and IL-18 production. Toxicology In Vitro: An International Journal Published in Association With BIBRA 2013, 27:103-110.
19. Goncalves R.B., Coletta R.D., Silverio K.G., Benevides L., Casati M.Z., da Silva J.S., Nociti F.H. Impact of smoking on inflammation: overview of molecular mechanisms. Inflammation Research: Official Journal of The European Histamine Research Society 2011, 60:409-424.
20. Health-Canada, 1999. Determination of "Tar", Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke. (Accessed 28.4.12).
21. Hecht, S.S., 2012. Lung carcinogenesis by tobacco smoke. International Journal of Cancer. Journal International Du Cancer.
22. Hecht S.S., Hoffmann D. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis 1988, 9:875-884.
23. Hellmann G.M., Fields W.R., Doolittle D.J. Gene expression profiling of cultured human bronchial epithelial and lung carcinoma cells. Toxicological Sciences 2001, 61:154-163.
24. Hoshino Y., Mio T., Nagai S., Miki H., Ito I., Izumi T. Cytotoxic effects of cigarette smoke extract on an alveolar type II cell-derived cell line. American Journal of Physiology. Lung Cellular and Molecular Physiology 2001, 281:L509-L516.
25. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009, 4:44-57.
26. Hukkanen J., Lassila A., Paivarinta K., Valanne S., Sarpo S., Hakkola J., Pelkonen O., Raunio H. Induction and regulation of xenobiotic-metabolizing cytochrome P450s in the human A549 lung adenocarcinoma cell line. American Journal of Respiratory Cell and Molecular Biology 2000, 22:360-366.
27. Ito K., Ito M., Elliott W.M., Cosio B., Caramori G., Kon O.M., Barczyk A., Hayashi S., Adcock I.M., Hogg J.C., Barnes P.J. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. The New England Journal of Medicine 2005, 352:1967-1976.
28. Kastner P.E., Casset A., Pons F. Formaldehyde interferes with airway epithelium integrity and functions in a dose- and time-dependent manner. Toxicology Letters 2011, 200:109-116.
29. Kawano T., Matsuse H., Fukahori S., Tsuchida T., Nishino T., Fukushima C., Kohno S. Acetaldehyde at a low concentration synergistically exacerbates allergic airway inflammation as an endocrine-disrupting chemical and as a volatile organic compound. Respiration; International Review of Thoracic Diseases 2012, 84:135-141.
30. Kempf T., Eden M., Strelau J., Naguib M., Willenbockel C., Tongers J., Heineke J., Kotlarz D., Xu J., Molkentin J.D., Niessen H.W., Drexler H., Wollert K.C. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circulation Research 2006, 98:351-360.
31. Kim J.H., Sherman M.E., Curriero F.C., Guengerich F.P., Strickland P.T., Sutter T.R. Expression of cytochromes P450 1A1 and 1B1 in human lung from smokers, non-smokers, and ex-smokers. Toxicology and Applied Pharmacology 2004, 199:210-219.
32. Lecureur V., Arzel M., Ameziane S., Houlbert N., Le Vee M., Jouneau S., Fardel O. MAPK- and PKC/CREB-dependent induction of interleukin-11 by the environmental contaminant formaldehyde in human bronchial epithelial cells. Toxicology 2012, 292:13-22.
33. Liu Y., Gao W., Zhang D. Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1 in a coculture system. Clinical and Experimental Medicine 2010, 10:159-167.
34. Mathijs K., Brauers K.J., Jennen D.G., Lizarraga D., Kleinjans J.C., van Delft J.H. Gene expression profiling in primary mouse hepatocytes discriminates true from false-positive genotoxic compounds. Mutagenesis 2010, 25:561-568.
35. McBride W.J., Li T.K., Deitrich R.A., Zimatkin S., Smith B.R., Rodd-Henricks Z.A. Involvement of acetaldehyde in alcohol addiction. Alcoholism, Clinical and Experimental Research 2002, 26:114-119.
36. Nakata K., Tanaka Y., Nakano T., Adachi T., Tanaka H., Kaminuma T., Ishikawa T. Nuclear receptor-mediated transcriptional regulation in Phase I, II, and III xenobiotic metabolizing systems. Drug Metabolism and Pharmacokinetics 2006, 21:437-457.
37. Neuss S., Holzmann K., Speit G. Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicology Letters 2010, 198:289-295.
38. Oyama T., Isse T., Ogawa M., Muto M., Uchiyama I., Kawamoto T. Susceptibility to inhalation toxicity of acetaldehyde in Aldh2 knockout mice. Frontiers in Bioscience 2007, 12:1927-1934.
39. Pascussi J.M., Gerbal-Chaloin S., Drocourt L., Assenat E., Larrey D., Pichard-Garcia L., Vilarem M.J., Maurel P. Cross-talk between xenobiotic detoxication and other signalling pathways: clinical and toxicological consequences. Xenobiotica; The Fate of Foreign Compounds in Biological Systems 2004, 34:633-664.
40. Pennings J.L., Rodenburg W., Imholz S., Koster M.P., van Oostrom C.T., Breit T.M., Schielen P.C., de Vries A. Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening. PLoS One 2011, 6:e18866.
41. Persoz C., Achard S., Leleu C., Momas I., Seta N. An in vitro model to evaluate the inflammatory response after gaseous formaldehyde exposure of lung epithelial cells. Toxicology Letters 2010, 195:99-105.
42. Qian Y., Zhang J., Yan B., Chen X. DEC1, a basic helix-loop-helix transcription factor and a novel target gene of the p53 family, mediates p53-dependent premature senescence. Journal of Biological Chemistry 2008, 283:2896-2905.
43. Rajendrasozhan S., Yao H., Rahman I. Current perspectives on role of chromatin modifications and deacetylases in lung inflammation in COPD. COPD 2009, 6:291-297.
44. Rezen T., Rozman D., Pascussi J.M., Monostory K. Interplay between cholesterol and drug metabolism. Biochimica et Biophysica Acta 2011, 1814:146-160.
45. Shimada A.L., Ribeiro A.L., Bolonheis S.M., Ferraz-de-Paula V., Hebeda C.B., Farsky S.H. In vivo hydroquinone exposure impairs MCP-1 secretion and monocyte recruitment into the inflamed lung. Toxicology 2012, 296:20-26.
46. Slob W. Dose-response modeling of continuous endpoints. Toxicological Sciences 2002, 66:298-312.
47. Speit G., Neuss S., Schmid O. The human lung cell line A549 does not develop adaptive protection against the DNA-damaging action of formaldehyde. Environmental and Molecular Mutagenesis 2010, 51:130-137.
48. Talhout R., Opperhuizen A., Vanamsterdam J. Role of acetaldehyde in tobacco smoke addiction. European Neuropsychopharmacology 2007, 17:627-636.
49. Tang M.S., Wang H.T., Hu Y., Chen W.S., Akao M., Feng Z., Hu W. Acrolein induced DNA damage, mutagenicity and effect on DNA repair. Molecular Nutrition & Food Research 2011, 55:1291-1300.
50. Thompson C.A., Burcham P.C. Genome-wide transcriptional responses to acrolein. Chemical Research in Toxicology 2008, 21:2245-2256.
51. Van Berkel J.J., Dallinga J.W., Moller G.M., Godschalk R.W., Moonen E., Wouters E.F., Van Schooten F.J. Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. Journal of chromatography B, Analytical Technologies in the Biomedical and Life Sciences 2008, 861:101-107.
52. van der Veen J.W., Pronk T.E., van Loveren H., Ezendam J. Applicability of a keratinocyte gene signature to predict skin sensitizing potential. Toxicology In Vitro: An International Journal Published in Association with BIBRA 2013, 27:314-322.
53. van Kesteren P.C., Zwart P.E., Pennings J.L., Gottschalk W.H., Kleinjans J.C., van Delft J.H., van Steeg H., Luijten M. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/-mice upon exposure to benzo[a]pyrene. Toxicological Sciences: An Official Journal of the Society of Toxicology 2011, 123:123-132.
54. Vandebriel R.J., Pennings J.L., Baken K.A., Pronk T.E., Boorsma A., Gottschalk R., Van Loveren H. Keratinocyte gene expression profiles discriminate sensitizing and irritating compounds. Toxicological Sciences: An Official Journal of the Society of Toxicology 2010, 117:81-89.
55. Verstraelen S., Nelissen I., Hooyberghs J., Witters H., Schoeters G., Van Cauwenberge P., Van Den Heuvel R. Gene profiles of a human bronchial epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicology 2009, 255:151-159.
56. Viswanath K., Herbst R.S., Land S.R., Leischow S.J., Shields P.G. Tobacco and cancer: an American Association for Cancer Research policy statement. Cancer Research 2010, 70:3419-3430.
57. Wang H., LeCluyse E.L. Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. Clinical Pharmacokinetics 2003, 42:1331-1357.
58. Watanabe K.H., Djordjevic M.V., Stellman S.D., Toccalino P.L., Austin D.F., Pankow J.F. Incremental lifetime cancer risks computed for benzo[a]pyrene and two tobacco-specific N-nitrosamines in mainstream cigarette smoke compared with lung cancer risks derived from epidemiologic data. Regulatory Toxicology and Pharmacology 2009, 55:123-133.
59. Watjen W., Beyersmann D. Cadmium-induced apoptosis in C6 glioma cells: influence of oxidative stress. Biometals: An International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine 2004, 17:65-78.
60. WHO, 2008. The scientific basis of tobacco product regulation. World Health Organization Technical Report Series. pp. 1-277.
61. Woutersen R.A., Appelman L.M., Feron V.J., Van der Heijden C.A. Inhalation toxicity of acetaldehyde in rats. II. Carcinogenicity study: interim results after 15months. Toxicology 1984, 31:123-133.
62. Woutersen R.A., Appelman L.M., Van Garderen-Hoetmer A., Feron V.J. Inhalation toxicity of acetaldehyde in rats. III. Carcinogenicity study. Toxicology 1986, 41:213-231.
63. Yuan J.M., Gao Y.T., Wang R., Chen M., Carmella S.G., Hecht S.S. Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers. Carcinogenesis 2012, 33:804-809.
64. Zeller J., Neuss S., Mueller J.U., Kuhner S., Holzmann K., Hogel J., Klingmann C., Bruckner T., Triebig G., Speit G. Assessment of genotoxic effects and changes in gene expression in humans exposed to formaldehyde by inhalation under controlled conditions. Mutagenesis 2011, 26:555-561.